(Q44899005)

7 December 2017

title

Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: a collaborative transplant study report (English)

1 reference

7 December 2017

0 references

organ transplantation

1 reference

1 reference

1

Gerhard Opelz

1 reference

7 December 2017

Bernd Döhler

2

1 reference

7 December 2017

Andrea Ruhenstroth

series ordinal

3

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

American Journal of Transplantation

7 December 2017

published in

1 reference

7 December 2017

volume

4

1 reference

7 December 2017

issue

6

1 reference

7 December 2017

page(s)

928-936

1 reference

Role of cytomegalovirus infection in allograft rejection: a review of possible mechanisms

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00451.X

Late-acute renal allograft rejection and symptomless cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00451.X

Cytomegalovirus infection and graft rejection in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00451.X

Diabetes Mellitus After Kidney Transplantation in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00451.X

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00451.X

Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00451.X

Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00451.X

Cytomegalovirus antibody status and renal transplantation: 1987-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00451.X

Cytomegalovirus infections following renal transplantation--effects on antiviral prophylaxis: a report of the North American Pediatric Renal Transplant Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00451.X

Cytomegalovirus infection and cardiac allograft vasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00451.X

Prevention of cytomegalovirus disease in recipients of solid-organ transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00451.X

A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00451.X

Prevention and treatment of cytomegalovirus disease in heart transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00451.X

10.1111/J.1600-6143.2004.00451.X

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference